🎧 🎉TYK-TOK we’re ready to rock PART 2!🎙️🎙️ The Skin and Joints Podcast Team continues the conversation with dermatologist dynamic duo Dr.Chih-Ho Hong and Dr.Irina Turchin who respectively lend their real world perspectives on a brand new oral therapy for our patients with moderate to severe psoriasis.  🛎️ Deucravacitinib is finally here! And we're going to be looking at fresh new data that could change your clinical practice.  We also break it down with our expert Faculty so you don't need to :) 🧵Where do our experts see the overall place  deucravacitinib in the therapeutic treatment pathway for moderate to severe psoriasis in the real world?🧵How does it compare with other biologics and non-biologic treatments?🫳 How effective is it for patients specifically with moderate to severe scalp, nail and palmoplantar psoriasis?  Episode Learning ObjectivesDescribe the overall place of deucravacitinib in the therapeutic treatment pathway for moderate to severe psoriasis in the real worldExamine the clinical efficacy associated with deucravacitinib and other select  biologic and nonbiologic treatments in patients with moderate to severe PsOExplore the correlations between responses on clinical and patient reported outcome (PRO) measures from  pooled data from POETYK PSO-1 and PSO-2 pivotal trialsEvaluate the efficacy of deucravacitinib treatment in patients with moderate to severe scalp, nail, and palmoplantar psoriasis  subgroup analyses pooled PSO-1 and PSO-2 data 
📻www.skinandjoints.ca✉️[email protected] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ver todos los episodios